Shujing Yue - Search Results

Year	Number of Results
2018	1
2019	2
2020	2
2021	5
2022	4

1

An intelligent cell-selective polymersome-DM1 nanotoxin toward triple negative breast cancer.

Zhang Y, Yue S, Haag R, Sun H, Zhong Z. Zhang Y, et al. Among authors: yue s. J Control Release. 2021 Dec 10;340:331-341. doi: 10.1016/j.jconrel.2021.11.014. Epub 2021 Nov 12. J Control Release. 2021. PMID: 34774889

2

Sustainable total-factor ecology efficiency of regions in China.

Shen Y, Yue S, Pu Z, Lai X, Guo M. Shen Y, et al. Among authors: yue s. Sci Total Environ. 2020 Sep 10;734:139241. doi: 10.1016/j.scitotenv.2020.139241. Epub 2020 May 15. Sci Total Environ. 2020. PMID: 32473449

3

Ecological development efficiency index of tropics and subtropics in China.

Shen Y, Sun S, Yue S, Sun X. Shen Y, et al. Among authors: yue s. Environ Sci Pollut Res Int. 2020 Apr;27(12):14160-14174. doi: 10.1007/s11356-020-07844-y. Epub 2020 Feb 10. Environ Sci Pollut Res Int. 2020. PMID: 32043248

4

CD38-Directed Vincristine Nanotherapy for Acute Lymphoblastic Leukemia.

Zhang Y, An J, Shao Y, Yu N, Yue S, Sun H, Zhang J, Gu W, Xia Y, Zhang J, Xu Y, Zhong Z. Zhang Y, et al. Among authors: yue s. Biomacromolecules. 2022 Jan 10;23(1):377-387. doi: 10.1021/acs.biomac.1c01342. Epub 2021 Dec 16. Biomacromolecules. 2022. PMID: 34913676

5

Daratumumab Immunopolymersome-Enabled Safe and CD38-Targeted Chemotherapy and Depletion of Multiple Myeloma.

Yu N, Zhang Y, Li J, Gu W, Yue S, Li B, Meng F, Sun H, Haag R, Yuan J, Zhong Z. Yu N, et al. Among authors: yue s. Adv Mater. 2021 Oct;33(39):e2007787. doi: 10.1002/adma.202007787. Epub 2021 Aug 8. Adv Mater. 2021. PMID: 34369013

6

Cetuximab-Polymersome-Mertansine Nanodrug for Potent and Targeted Therapy of EGFR-Positive Cancers.

Yue S, Zhang Y, Wei Y, Haag R, Sun H, Zhong Z. Yue S, et al. Biomacromolecules. 2022 Jan 10;23(1):100-111. doi: 10.1021/acs.biomac.1c01065. Epub 2021 Dec 16. Biomacromolecules. 2022. PMID: 34913340

7

HER2-Specific Reduction-Sensitive Immunopolymersomes with High Loading of Epirubicin for Targeted Treatment of Ovarian Tumor.

Ding L, Gu W, Zhang Y, Yue S, Sun H, Cornelissen JJLM, Zhong Z. Ding L, et al. Among authors: yue s. Biomacromolecules. 2019 Oct 14;20(10):3855-3863. doi: 10.1021/acs.biomac.9b00947. Epub 2019 Sep 30. Biomacromolecules. 2019. PMID: 31513391

8

Does financial development promote the win-win balance between environmental protection and economic growth?

Yue S, Lu R, Chen H, Yuan J. Yue S, et al. Environ Sci Pollut Res Int. 2018 Dec;25(36):36438-36448. doi: 10.1007/s11356-018-3549-y. Epub 2018 Oct 29. Environ Sci Pollut Res Int. 2018. PMID: 30370466

9

Can green credit increase firm value? Evidence from Chinese listed new energy companies.

Lai X, Yue S, Chen H. Lai X, et al. Among authors: yue s. Environ Sci Pollut Res Int. 2022 Mar;29(13):18702-18720. doi: 10.1007/s11356-021-17038-9. Epub 2021 Oct 25. Environ Sci Pollut Res Int. 2022. PMID: 34697707

10

Dually Active Targeting Nanomedicines Based on a Direct Conjugate of Two Purely Natural Ligands for Potent Chemotherapy of Ovarian Tumors.

Yan Y, Dong Y, Yue S, Qiu X, Sun H, Zhong Z. Yan Y, et al. Among authors: yue s. ACS Appl Mater Interfaces. 2019 Dec 18;11(50):46548-46557. doi: 10.1021/acsami.9b17223. Epub 2019 Dec 9. ACS Appl Mater Interfaces. 2019. PMID: 31763810

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results